Article
Worldwide Prevalence of Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer: A Meta-Analysis.
Molecular diagnosis & therapy - 1 Jan 2022
Melosky Barbara, Kambartel Kato, Häntschel Maik, Bennetts Margherita, Nickens Dana J, Brinkmann Julia, Kayser Antonin, Moran Michael, Cappuzzo Federico
Abstract excerpt
BACKGROUND: Identification of variable epidermal growth factor receptor (EGFR) gene mutations in non-small cell lung cancer (NSCLC) is important for the selection of appropriate targeted therapies. This meta-analysis was conducted to provide a worldwide overview of EGFR mutation and submutation (specifically exon 19 deletions, exon 21 L858R substitutions, and others) prevalence, and identify important covariates...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
